4 big analyst cuts: Disney slashed at KeyBanc amid 'meaningful uncertainty'
Investing.com | Author Davit Kirakosyan
Published Jun 29, 2023 06:09AM ET
Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Pfizer, Walt Disney, Delek Logistics, and Inter.
Never miss another market-moving headline.
Walt Disney downgraded at KeyBanc/h2
KeyBanc cut Walt Disney (NYSE:DIS) to Sector Weight from Overweight, noting it prefers to step aside and wait for further catalysts amid a period of "meaningful uncertainty." It added, "Buying the dip has been a losing trade."
The firm delineated five reasons for the downgrade:
1) DIS Domestic Parks expectations appear high;
2) DIS DTC [direct-to-consumer] subscriber growth has stalled, and DIS has failed to differentiate its DTC churn vs. peers;
3) ESPN moving to streaming is materially harder than we initially thought, as our survey work shows low willingness to pay;
4) structural changes in content distribution have resulted in DIS content sales segment business that is unlikely to make money for the foreseeable future; and
5) we worry the 2024 financial setup feels a lot like 2023.
Pfizer downgraded to Neutral/h2
Credit Suisse downgraded Pfizer (NYSE:PFE) to Neutral from Outperform and cut its price target to $40.00 from $47.00, as reported in real-time on
Get The News You Want
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.